Susquehanna International Group’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-644
Closed -$23.5K 13142
2023
Q4
$23.5K Hold
644
﹤0.01% 11942
2023
Q3
$8.21K Hold
644
﹤0.01% 11741
2023
Q2
$19.5K Sell
644
-16
-2% -$922 ﹤0.01% 11641
2023
Q1
$67.8K Buy
660
+631
+2,176% +$119K ﹤0.01% 11543
2022
Q4
$4.1K Buy
29
+8
+38% +$3.46K ﹤0.01% 12070
2022
Q3
$11K Sell
21
-5
-19% -$4.36K ﹤0.01% 12760
2022
Q2
$23K Sell
26
-39
-60% -$53.5K ﹤0.01% 12330
2022
Q1
$163K Sell
65
-174
-73% -$413K ﹤0.01% 11479
2021
Q4
$616K Sell
239
-131
-35% -$524K ﹤0.01% 8596
2021
Q3
$1.69M Buy
370
+20
+6% +$136K ﹤0.01% 6197
2021
Q2
$2.41M Buy
350
+78
+29% +$538K ﹤0.01% 5495
2021
Q1
$1.99M Buy
272
+189
+228% +$1.59M ﹤0.01% 5933
2020
Q4
$670K Sell
83
-77
-48% -$692K ﹤0.01% 7643
2020
Q3
$1.63M Buy
160
+71
+80% +$582K ﹤0.01% 5005
2020
Q2
$598K Buy
+89
New +$613K ﹤0.01% 6996
2019
Q3
Sell
-11
Closed -$72K 10704
2019
Q2
$72K Sell
11
-4
-27% -$30.8K ﹤0.01% 9739
2019
Q1
$123K Buy
15
+2
+15% +$15.8K ﹤0.01% 8163
2018
Q4
$70K Sell
13
-3
-19% -$23K ﹤0.01% 8365
2018
Q3
$144K Sell
16
-2
-11% -$16.3K ﹤0.01% 8439
2018
Q2
$154K Buy
+18
New +$114K ﹤0.01% 8822

Other funds holding RDHL

Susquehanna International Group's RDHL Position: Q1 2023 in Review

Susquehanna International Group sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 16 shares — an estimated $3.02K sold.

Susquehanna International Group first reported a position in RDHL in Q3 2019 and held it in 14 quarters. The position peaked at $2.15M in Q1 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Susquehanna International Group reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 16 Redhill Biopharma shares in Q1 2023, an estimated $3.02K.
  • Susquehanna International Group first reported a position in Redhill Biopharma in Q3 2019 and held it in 14 quarters.
  • Susquehanna International Group's Redhill Biopharma position peaked at $2.15M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.